Hochschulschrift
Enhancing anti-tumor immunity to MHC class I-deficient tumors : role of regulatory T cells and type I IFN
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Heidelberg, Univ., Diss., 2008
- Keyword
-
Tumorimmunologie ; Makrophage ; Interferon ; Natürliche Killerzelle
T-Lymphozyt
Zelluläre Immunität
Signaltransduktion
Tierphysiologie
Maus
- Creator
- URN
-
urn:nbn:de:bsz:16-opus-84971
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:45 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Metabolic reprogramming in SIRT6-deficient hepatoblastoma cells and impact on anti-tumor response of macrophages
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
Investigation of non-traditional platinum anti-tumor agents
Anti-tumor functions CD40L-expressing CD8+ T cell
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Cytokine-induced senescence in the tumor microenvironment and its effects on anti-tumor immune responses
Anti-Tumor Antikörper mit verbesserter Rekrutierung von Weichteil- und Knochensarkomen
Group 3 innate lymphoid cells and their anti-tumor responses
Molecular mechanisms of the RIG-I mediated anti-tumor immunity
Directed evolution of arginine deiminase (ADI) for anti-tumor application
Metabolic reprogramming in SIRT6-deficient hepatoblastoma cells and impact on anti-tumor response of macrophages
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
Investigation of non-traditional platinum anti-tumor agents
Anti-tumor functions CD40L-expressing CD8+ T cell
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Cytokine-induced senescence in the tumor microenvironment and its effects on anti-tumor immune responses
Anti-Tumor Antikörper mit verbesserter Rekrutierung von Weichteil- und Knochensarkomen
Group 3 innate lymphoid cells and their anti-tumor responses
Molecular mechanisms of the RIG-I mediated anti-tumor immunity
Directed evolution of arginine deiminase (ADI) for anti-tumor application
Metabolic reprogramming in SIRT6-deficient hepatoblastoma cells and impact on anti-tumor response of macrophages
Selected anti-tumor vaccines merit a place in multimodal tumor therapies
Investigation of non-traditional platinum anti-tumor agents
Anti-tumor functions CD40L-expressing CD8+ T cell
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Modulation of antitumor immunity by isocitrate dehydrogenase-mutated tumors
Cytokine-induced senescence in the tumor microenvironment and its effects on anti-tumor immune responses
Anti-Tumor Antikörper mit verbesserter Rekrutierung von Weichteil- und Knochensarkomen
Group 3 innate lymphoid cells and their anti-tumor responses
Molecular mechanisms of the RIG-I mediated anti-tumor immunity